CCL2 and diabetic kidney disease: The blockade of CCL2/CCR2 signaling by RS102895 reportedly ameliorates diabetic nephropathy by improving blood glucose levels and preventing CCL2/CCR2 signaling from altering renal nephrin and VEGF expressions through blocking macrophage infiltration, inflammation, and oxidative stress in type 2 diabetic mice [19].